## 3 Results  
A total of seven children (five males and two females, aged 4-10 years) were included in the study (Table 1 presents participant characteristics). All seven children completed the first phase of the study. However, during the second phase, one participant withdrew and did not undergo TR treatment. In the first phase, the median number of treatment sessions completed was 34 (range: 29-37 sessions), and the median length of hospitalization was 29 days (range: 18-33 days). In the second phase, the median number of sessions completed was nine (range: 6-13 sessions). Regarding the primary outcome measure, there was a significant change over time in the MA2-Range of movement score (\(\chi^{2}(2)=11.2\), \(p=0.004\); \(\eta^{2}\): 0.2) and in the MA2-Fluency of movement score (\(\chi^{2}(2)=6.74\), \(p=0.034\); \(\eta^{2}\): 0.2). As shown in Table 2 (see also Figures 4 and 5; box plots related to the outcome measures at different assessment points are shown in the Supplementary Materials), the Durbin-Conover pairwise comparison test revealed a statistically significant increase in the MA2-Range of movement score over time between the assessment at T0 and T1, as well as between T0 and T2, while the change from T1 to T2 was not statistically significant. The Durbin-Conover test also indicated a statistically significant increase in the MA2-Fluency of movement score from T0 to T1 and from T0 to T2, but no significant change from T1 to T2. The increase in other MA2 scores, such as the MA2-Accuracy of Reach and Placement and MA2-Dexterity in Grasp, Release, and Manipulation scores, was only marginally statistically significant (MA2-ARP: \(\chi^{2}(2)\) = 5.70, \(p\) = 0.058; MA2-DEX: \(\chi^{2}(2)\) = 5.44, \(p\) = 0.06). For the secondary outcome measure, we observed a statistically significant increase over time in certain Parent-PedsQL scores: Parent-PedsQL Daily Activities score (\(\chi^{2}(2)\) = 9.33, \(p\) = 0.009; \(\eta^{2}\): 0.3), Parent-PedsQL 3.0 Movement and Balance score (\(\chi^{2}(2)\) = 7.28, \(p\) = 0.026; \(\eta^{2}\): 0.3), and Parent-PedsQL Fatigue score (\(\chi^{2}(2)\) = 9.29, \(p\) = 0.010; \(\eta^{2}\): 0.2). The Durbin-Conover pairwise comparison test indicated that the P-PedsQL Daily Activities score increased significantly from T0 to T2, as well as from T1 to T2. Additionally, the Parent-PedsQL Movement and Balance score showed a statistically significant increase only from T0 to T2, while the Parent-PedsQL Fatigue score increased significantly from T0 to T1 and from T0 to T2. No significant changes were observed over time for the other secondary outcome measures. A marginally significant increase in the Besta B score was found (\(\chi^{2}(2)\) = 5.60, \(p\) = 0.06). Finally, the mean SUS score was 72.5. \begin{table}
\begin{tabular}{c c} \hline \hline
**Sex N (\%)** & \\ \hline Male & 5 (71.4\%) \\ \hline Female & 2 (28.6\%) \\ \hline
**Age** & \\ \hline Mean age (Standard Deviation) & 6.82 (2.08) \\ \hline Age range & 4.25–10.6 \\ \hline
**QI Mean (Standard Deviation)** & 88 (16.2) \\ \hline
**Side of motor impairment N (\%)** & \\ \hline Right & 4 (57.1\%) \\ \hline Left & 3 (42.9\%) \\ \hline
**GMFCS N (\%)** & \\ \hline Level 1 & 3 (42.9\%) \\ \hline Level 2 & 4 (57.1\%) \\ \hline
**MACS N (\%)** & \\ \hline Level 1 & 1 (14.3\%) \\ \hline Level 2 & 6 (85.7\%) \\ \hline
**VFCS N (\%)** & \\ \hline Level 1 & 7 (100\%) \\ \hline Level 2 & 0 (0\%) \\ \hline \hline \end{tabular}
\end{table} 
Table 1: Participant characteristics. Figure 4: Graphical representation of the average MA2_RM score observed during each of the three assessments conducted at different time points: before starting inpatient treatment (T0), after completing inpatient treatment (T1), and after finishing tele-rehabilitation (TR). The figure visually shows the changes in mean scores over time across the three assessment points.